PD-L2/B7-DC/PDCD1LG2 Antibody

B7-DC is also called programmed death ligand 2 (PDL2). It has recently been clustered as CD273. This ligand is a 42 kD member of the immunoglobulin receptor superfamily expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. B7-DC (CD273) has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. B7-DC (CD273) has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: IF/IHC.

Showing Publications 1 - 3 of 3.

Publications using NBP1-88964	Applications	Species
Li W, Qie J, Zhang Y, Chang J Spatiotemporal Changes in Checkpoint Molecule Expression Adv. Exp. Med. Biol. 2020-03-19 [PMID: 32185711]
Xing X, Guo J, Wen X et al. Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients OncoImmunology [PMID: 29399387] (IF/IHC, Human)	IF/IHC	Human
Zhang Y, Wang L, Li Y et al. Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma. Onco Targets Ther 2014-01-01 [PMID: 24748806]

Array NBP1-88964

• PD-L2/B7-DC/PDCD1LG2 Antibodies
• PD-L2/B7-DC/PDCD1LG2 Antibody Pair
• PD-L2/B7-DC/PDCD1LG2 Lysate
• PD-L2/B7-DC/PDCD1LG2 Proteins
• PD-L2/B7-DC/PDCD1LG2 ELISA
• PD-L2/B7-DC/PDCD1LG2 Proteins and Enzymes